🎉 M&A multiples are live!
Check it out!

10x Genomics Valuation Multiples

Discover revenue and EBITDA valuation multiples for 10x Genomics and similar public comparables like Sonic Healthcare, Bangkok Dusit Medical Services, and Australian Clinical Labs.

10x Genomics Overview

About 10x Genomics

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).


Founded

2012

HQ

United States of America
Employees

1.3K+

Website

10xgenomics.com

Financials

LTM Revenue $611M

LTM EBITDA -$163M

EV

$954M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

10x Genomics Financials

10x Genomics has a last 12-month revenue of $611M and a last 12-month EBITDA of -$163M.

In the most recent fiscal year, 10x Genomics achieved revenue of $611M and an EBITDA of -$134M.

10x Genomics expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See 10x Genomics valuation multiples based on analyst estimates

10x Genomics P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $619M $611M XXX XXX XXX
Gross Profit $396M $409M XXX XXX XXX
Gross Margin 64% 67% XXX XXX XXX
EBITDA -$205M -$134M XXX XXX XXX
EBITDA Margin -33% -22% XXX XXX XXX
Net Profit -$166M -$255M XXX XXX XXX
Net Margin -27% -42% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

10x Genomics Stock Performance

As of March 14, 2025, 10x Genomics's stock price is $10.

10x Genomics has current market cap of $1.3B, and EV of $954M.

See 10x Genomics trading valuation data

10x Genomics Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$954M $1.3B XXX XXX XXX XXX $-1.51

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

10x Genomics Valuation Multiples

As of March 14, 2025, 10x Genomics has market cap of $1.3B and EV of $954M.

10x Genomics's trades at 1.6x LTM EV/Revenue multiple, and -5.8x LTM EBITDA.

Analysts estimate 10x Genomics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for 10x Genomics and 10K+ public comps

10x Genomics Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $954M XXX XXX XXX
EV/Revenue 1.6x XXX XXX XXX
EV/EBITDA -7.1x XXX XXX XXX
P/E -6.9x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -141.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get 10x Genomics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

10x Genomics Valuation Multiples

10x Genomics's NTM/LTM revenue growth is 2%

10x Genomics's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.5M for the same period.

Over next 12 months, 10x Genomics's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate 10x Genomics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for 10x Genomics and other 10K+ public comps

10x Genomics Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -1% XXX XXX XXX XXX
EBITDA Margin -22% XXX XXX XXX XXX
EBITDA Growth -35% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -20% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.5M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 43% XXX XXX XXX XXX
Opex to Revenue 100% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

10x Genomics Public Comps

See public comps and valuation multiples for Laboratory Services and Genomics & Personalized Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
Integral Diagnostics XXX XXX XXX XXX XXX XXX
Sonic Healthcare XXX XXX XXX XXX XXX XXX
Bangkok Dusit Medical Services XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

10x Genomics M&A and Investment Activity

10x Genomics acquired  XXX companies to date.

Last acquisition by 10x Genomics was  XXXXXXXX, XXXXX XXXXX XXXXXX . 10x Genomics acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by 10x Genomics

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About 10x Genomics

When was 10x Genomics founded? 10x Genomics was founded in 2012.
Where is 10x Genomics headquartered? 10x Genomics is headquartered in United States of America.
How many employees does 10x Genomics have? As of today, 10x Genomics has 1.3K+ employees.
Who is the CEO of 10x Genomics? 10x Genomics's CEO is Dr. Serge Saxonov, PhD.
Is 10x Genomics publicy listed? Yes, 10x Genomics is a public company listed on NAS.
What is the stock symbol of 10x Genomics? 10x Genomics trades under TXG ticker.
When did 10x Genomics go public? 10x Genomics went public in 2019.
Who are competitors of 10x Genomics? Similar companies to 10x Genomics include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare.
What is the current market cap of 10x Genomics? 10x Genomics's current market cap is $1.3B
What is the current revenue of 10x Genomics? 10x Genomics's last 12-month revenue is $611M.
What is the current EBITDA of 10x Genomics? 10x Genomics's last 12-month EBITDA is -$163M.
What is the current EV/Revenue multiple of 10x Genomics? Current revenue multiple of 10x Genomics is 1.6x.
What is the current EV/EBITDA multiple of 10x Genomics? Current EBITDA multiple of 10x Genomics is -5.8x.
What is the current revenue growth of 10x Genomics? 10x Genomics revenue growth between 2023 and 2024 was -1%.
Is 10x Genomics profitable? Yes, 10x Genomics is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.